Table 2.
miRNAs as biomarkers in HER2+ breast cancer.
miRNA | Reference | Value in HER2+ Breast Cancer |
---|---|---|
miR-451a, miR-16-5p, miR-17-3p, miR-940 | Li H et al. (2018) [60] | Predictor of response and prognostic role |
miR-27b, miR-433, miR-16,
miR-328, miR-660, miR-422a |
Stevic et al. (2018) [67] | Predictive role, association with N-status, distinction between TNBC and HER2+ BC |
miR-21 | Liu et al. (2019) [68] | Predictor of response |
miR-222-3p | Zhang et al. (2020) [69] | Predictive and prognostic role and association with cardiotoxicity and anemia, side effects of trastuzumab therapy |
miR-205 | Cataldo et al. (2018) [72] | Predictor of response and prognostic role |
miR-675, miR-204 | Müller et al. (2019) [73] | Indicators of disease aggressiveness |
miR-100-5p, miR-374a-5p, miR-574-3p, miR-140-5p, miR-328-3p, miR-145-5p, miR-34a-5p, miR-98-5p, miR-100-5p,
miR-144-3p, miR-362-3p, miR-197-3p, miR-320c, miR-100-5p, miR-376c-3p, miR-874-3p, |
Di Cosimo et al. (2019) [64] | Predictive and prognostic role |
miR-148a-3p, miR-374a-5p | Di Cosimo et al. (2020) [65] | Predictive role |
miR-215-5p,
miR-30c-2-3p, miR-153-3p, miR-219a-5p, miR-31-3p, miR-382-3p |
Pizzamiglio and Cosentino et al. (2021) [66] | Predictive and prognostic role |